We apologize for any inconveniences as the site is being expanded with new modules & functionalities being added.

BREAKING NEWS
News
Latests Medical News from around the world and also Thailand, bringing you updates, discoveries, studies and findings on various aspects and diseases in the medical world. Most of these articles are not only meant for Doctors In Thailand or Hospitals In Thailand but also for any patients or health conscious individuals wanting to know more.
Source: COVID-19-News  Jul 15, 2020  29 minutes ago
COVID-19 News: In a new detailed study conducted by researchers from the University Hospital of Salamanca in Spain that was funded by the Spanish Ministry For Science, in was found that more than 40 percent of 139 health care workers who had recovered from COVID-19 were found to have Pericarditis Or/And Myocarditis when they were examined about 10 weeks later. More than 42 % experienced symptoms a...
Source: COVID-19 Rehab  Jul 15, 2020  2 hours ago
COVID-19 Rehab: As the number of confirmed global COVID-19 cases is fast approaching 14 million and many experts are saying that the numbers could actually be as high as 10 to 20 times that figure due to underreporting by many countries and also due to concealments in some cases, it is becoming apparent day by day and an emerging fact that there is a whole list of long term health complications ar...
Source: COVID-19 Vaccine  Jul 15, 2020  4 hours ago
COVID- 19 Vaccine: Canadian biophamaceutical company Medicago that is based in Quebec with branches in the U.S. announced that it has begun Phase I clinical trial for its plant-derived COVID-19 vaccine candidate. It has already administered the first doses of the candidate in healthy human subjects, and the company intends to initiate a Phase II/III trial this coming October.   Dr Nath...
Source: COVID-19 Vaccine  Jul 15, 2020  7 hours ago
COVID-19 Vaccine: American researchers from Duke University-Durham have made an important discovery about the spike protein SARS-CoV-2 that could have a broad impact on vaccine studies.   The S or spike protein is the structure that binds to host cell angiotensin-converting enzyme 2 (ACE2) to enable viral attachment and entry during the infection process. The spike protein is also...
Source: COVID-19 Research  Jul 15, 2020  8 hours ago
COVID-19 Research: According to an international study led by the University of Cincinnati College of Medicine, depressed mood or anxiety exhibited in COVID-19 patients may possibly be a sign that the SARS-CoV-2 coronavirus is affecting the central nervous system.   The research findings are published in the journal: Laryngoscope. https://onlinelibrary.wiley.com/doi/abs/10.1002/lary.28964 &...
Source: COVID-19 Research  Jul 14, 2020  18 hours ago
COVID-19 Research: Researchers from New York University Langone Health in a retrospective study, found that the viral load of SARS-CoV-2 collected from patients in the emergency department is significantly higher in patients with fewer or milder symptoms who did not require hospitalization, the opposite of what might be expected. They also found that a patient's history of cancer and cardiovas...
Source: COVID-19 Pandemic  Jul 14, 2020  21 hours ago
COVID-19 Pandemic:  A modeling study by Imperial College London and Oxford University predicts that the global healthcare industry will be disrupted the next 5 years due to the COVID-19 pandemic and that there will be a huge surge in deaths for those who contract or are suffering from HIV, TB and Malaria.   Certain low- and middle-income countries (LMICs) could see HIV, tuber...
Source: COVID-19 Supplements-Zinc  Jul 14, 2020  23 hours ago
COVID-19 Supplements: It seems that certain doctors, (those unethical ones getting commissions from Pharma giants), fact checkers (those buffoons who failed in their careers and work as fact checkers for garbage companies like Facebook) and certain corrupted  government authorities tend to have an affinity for always discounting the fact that vitamins, supplements and herbs could help in cert...
Source: SARS-CoV-2 Spike Protein  Jul 14, 2020  1 day ago
SARS-CoV-2  Spike Protein: In most of the research concerning  vaccine and antiviral development, the key target is the spike (S) protein of the SAR-CoV-2 coronavirus, a trimeric component of the viral particle that is responsible for binding to the host receptor, ie the angiotensin-converting enzyme 2 (ACE2).   A new research by scientists from Janssen Vaccines & Prevention B...
Source: COVID-19 Symptoms  Jul 14, 2020  1 day ago
COVID-19 Symptoms: Medical researchers from King’s College London and Zoe Global Ltd have conducted a study suggesting that skin rashes could be valuable predictors of coronavirus disease 2019 (COVID-19).   The research finds are being peer-reviewed and are currently published on a preprint server. https://www.medrxiv.org/content/10.1101/2020.07.10.20150656v1   The large and deta...
Source: COVID-19 Vaccine  Jul 14, 2020  1 day ago
COVID-19 Vaccine: There are more than 140 SARS-CoV-2 vaccines in development and the race for a successful candidate to help prevent COVID-19 is making many researchers jumpstart processes and in some cases even by pass safety protocols.   Although an effective and safe vaccine would be a major advance in the fight against COVID-19, there are challenges in evaluating the efficacy of&nb...
Source: COVID-19 Immunity  Jul 14, 2020  1 day ago
COVID-19 Immunity: Researchers from King’s College London and Guy’s and St Thomas’ NHS Foundation Trust in a long and detailed study discovered that there is a rapid decline in the levels of SARS-CoV-2 neutralizing antibodies during the weeks following initial infection. This raises questions over the potential for re-infection, the effectiveness that may be expected from va...
Source: COVID-19 Antibodies  Jul 13, 2020  2 days ago
COVID-19 Antibodies: A new research led Scripps Research Institute has discovered a common molecular feature found in many of the human antibodies that neutralize SARS-CoV-2, the coronavirus that causes COVID-19.   The researchers reviewed data on nearly 300 anti-SARS-CoV-2 antibodies that their labs and others have found in convalescent COVID-19 patients over the past few months....
Source: COVID-19 Vaccine  Jul 13, 2020  2 days ago
COVID-19 Vaccine: Maryland based Altimmune, Inc., a clinical-stage biopharmaceutical company, has reported positive results from the preclinical studies conducted in mice at the University of Alabama at Birmingham of its intranasal COVID-19 vaccine candidate, AdCOVID.   The research studies; a collaboration between the University of Alabama-Birmingham and Altimmune showed strong serum neutr...
Source: Thailand COVID-19  Jul 13, 2020  2 days ago
Thailand COVID-19: Thailand is reporting new COVID-19 cases from foreigners and Thais coming from Muslim countries like Pakistan, Egypt, UAE, Kuwait etc. Many local Thais are getting upset with the government for allowing flights to resume from these countries and are calling for a ban for all flights and arrivals from these countries.   In what is now becoming a major health scare that is ...
Source: COVID-19 Drugs  Jul 13, 2020  2 days ago
COVID-19 Drugs: A relatively large and detailed clinical trial performed by Japanese researchers has showed inconclusive data from Covid-19 patients treated with Fujifilm’s Avigan drug also known as favipiravir. Fujita Health University researcher Professor Dr Yohei Doi said that the drug led to improvement in patients treated early, compared to those who received delayed dose...
Source: China COVID-19 News  Jul 13, 2020  2 days ago
China COVID-19 News:  A prominent Chinese doctor from Renmin Hospital of Wuhan University who has been supplying us with research studies and information but on conditions of anonymity since the start of the outbreak has claimed to say that the situation in China is more dire that thought as he claims that millions of Chinese country wide are infected with the SARS-CoV-2 coronavirus but do no...
Source: COVID-19 Immunology  Jul 13, 2020  2 days ago
COVID-19 Immunology:  A new study by German researchers from Saarland University shows that there are higher levels of anti-SARS-CoV-2 T cells, which show significant alterations in the phenotype and function in COVID-19 patients.   Initial research had already shown that the SARS-CoV-2 coronavirus causes broad changes in cellular immune response, seen chiefly as lymphopenia, altera...
Source: COVID-19 Innovations  Jul 13, 2020  2 days ago
COVID-19 Mask: Medical and Engineering Researchers from MIT and Harvard’s Brigham and Women’s Hospital have designed a new face mask that they believe could stop viral particles as effectively as N95 masks. Unlike N95 masks, the new masks were designed to be easily sterilized and used many times. The masks are based on the shape of the 3M 1860 style of N95 masks, the type n...
Source: COVID-19 Cellular Therapy  Jul 13, 2020  2 days ago
COVID-19 Cellular Therapy. Spanish researchers announced that a cellular therapy tested on 13 intubated patients with mechanical ventilation has shown to be efficient for the clinical improvement of critical cases of COVID-19.   The research which is the broadest published to date in these conditions, has been published in journal: The Lancet's EClinical Medicine, after proving that the...
Source: COVID-19 Research  Jul 13, 2020  2 days ago
COVID-19 Research: Researchers from the department of molecular medicine at Scripps Research Institute - Florida in a new study have discovered that cholesterol saturation in host cells helps to facilitate viral entry of the SARS-CoV-2 coronavirus.   Their research findings were published on a preprint server but are yet to have been peer-reviewed. https://www.biorxiv.org/content/10.1101/20...
Source: Hand Sanitizer  Jul 12, 2020  3 days ago
Hand Sanitizer Reaction: A report was published in the Oxford journal: Alcohol and Alcoholism in which a case study was highlighted involving Disulfiram-Ethanol reactions by hand-sanitizer usage. The case warn patients recovering from alcoholic addiction and are on the drug Disulfiram to be ware when using ethanol containing hand sanitizers. https://academic.oup.com/alcalc/article-abstract/55/4/34...
Source: COVID-19 Antibodies  Jul 12, 2020  3 days ago
COVID-19 Antibodies: One of Boehringer Ingelheim’s research programs has uncovered unique 28 antibodies that the company plans to move into further testing.   A study team led by Cologne University Hospital and the German Center for Infection Research studied the antibody response to COVID-19 in 12 people who recovered from the virus, as well as immune cells from 48 healthy people col...
Source: COVID-19 Meds  Jul 12, 2020  3 days ago
COVID-19 Meds: With more than 140 vaccine projects and more than 420 drug trials under way and governments in Europe and the United States investing billions of dollars in research, trials and manufacturing, there is concern that richer nations could scoop up promising medicines against the new coronavirus, leaving developing countries empty-handed. Bill Gates, Billionaire philanthropist (wish h...
Source: Remdesivir  Jul 12, 2020  3 days ago
Remdesivir: Pharma giant Gilead Sciences wasted no time beginning testing of an inhaled formulation of its COVID-19 drug remdesivir for mild and less severe COVID-19 patients with the hope that the US FDA and Trump administration will support its approval again and buy up overpriced stocks once again with tax payers monies. We are not sure what basis the inhaled version of the drug will be approve...
Source: Cancer Treatments  Jul 12, 2020  3 days ago
Cancer Treatments: Oncology researchers from Stanford University and Washington State University have demonstrated that a fatty acid called dihomogamma-linolenic acid, or DGLA, can be used to target and kill human cancer cells.   The research findings published in the journal: Developmental Cell, found that DGLA can induce ferroptosis in an animal model and in actual human cancer cells...
Source: COVID-19 Latest  Jul 12, 2020  3 days ago
COVID-19 Latest: More than 55 European researchers from 13 research centers across Germany, Netherlands and Greece provide the first evidence for the use of whole blood transcriptomics to distinguish COVID-19 disease from other infections, and also to monitor and potentially predict disease outcomes. Such as approach helps further dissect molecular phenotypes and stratify COVID-19 patients, as wel...
Source: COVID-19 Research  Jul 12, 2020  3 days ago
COVID-19 Research: European researchers from Universitair Ziekenhuis Leuven-Belgium, Karolinska Institutet-Sweden, Dresden University of Technology-Germany, University of Cambridge-UK and University of Oslo-Norway have in a new collaborative study shown that genes involved in severe SARS-CoV-2 coronavirus infection are expressed to a higher degree in older heart muscle cells or cardiomyocytes than...
Source: COVID-19 Virucides  Jul 11, 2020  4 days ago
COVID-19 Virucides: Researchers from Duke-NUS Medical School In Singapore shows that Povidone-Iodine demonstrates rapid in vitro virucidal activity against sars-cov-2 coronavirus in a new study. The research findings were published in the journal: Infectious Disease and Therapy Journal. https://link.springer.com/article/10.1007/s40121-020-00316-3   Povidone-iodine (PVP-I), which is highly ef...
Source: Thailand Medical News  Jul 11, 2020  4 days ago
We need help from our readers! Payment Gateway Suggestions, Volunteer Spanish Translators, Japanese Translators, SEO Specialist, Fund Raisers, Writer and Rewriters We are just a two man team that works with numerous research entities, medical schools and labs around the world and we operate a few medical and health sites by ourselves. We need kind hearted individuals who wish to volunteer thei...
Source: COVID-19 Aerosol Box  Jul 11, 2020  4 days ago
COVID-19 Aerosol Boxes meant to protect doctors and nurses when they intubate COVID-19 patients may actually increase their exposure to airborne SARS-CoV-2 coronavirus particles according to a new Australian study.   The study findings are published in the journal: Anaesthesia,the  official journal of the Association of Anaesthetists. https://onlinelibrary.wiley.com/doi/full/10.1111/an...
Source: COVID-19 Latest  Jul 11, 2020  4 days ago
COVID-19 Latest: Emerging research from China shows that certain COVID-19 patients without a previous diagnosis of diabetes are showing abnormally high blood sugar and this  is often associated with more than double the risk of death and also an increased risk of severe complications. One of the possible explanations for this phenomenon is that the endocrine system is being affected along wit...
Source: COVID-19 News  Jul 11, 2020  4 days ago
COVID-19 News: Researchers from the University Of Basel have published a new study that focuses of the epidemiology of SARS-CoV-2 emergence amidst Community-Acquired Respiratory Viruses(CARVs) with implications of what we can expect in the coming winter.   The study traces how COVID-19 became the predominant cause of respiratory infection in the period from early January until the present. ...
Source:   Jul 10, 2020  5 days ago
New Viral Pneumonia:The Chinese embassy in Kazakhstan has warned of a deadly “unknown pneumonia” after the former Soviet republic reported a spike in pneumonia cases since June.The embassy that that is not the current SARS-CoV-2 coronavirus but stopped short of saying what it was. The embassy said in a warning to Chinese citizens in the country, “The death rate of this disease ...
Source: COVID-19 Diagnostics  Jul 10, 2020  5 days ago
COVID-19 Diagnostics: American researchers led by the Cedars-Sinai Medical Center and University Of Connecticut have developed highly specific and sensitive assays that could improve understanding of the antibody response in the COVID-19 disease and also help to determine the effectiveness of vaccines.   The new assays uncovered dynamic changes in the level of antibodies against the SARS-Co...
Source: U.S. Medical News  Jul 10, 2020  5 days ago
US COVID-19 News: America posted 65,551 new COVID-19 cases in the last 24 hours, a record for a 24-hour period, according to a tally by Johns Hopkins University.   USA is the hardest-hit country in the world by the pandemic, has a total caseload of more than 3.22 million, with 135,018 deaths. (As of 10th July, 3am California,m Source  Worldometer)   It was also reported that more ...
Source: COVID-19 Clinical Trials  Jul 10, 2020  5 days ago
COVID-19 Clinical Trials: Medical researchers from the University of California San Diego School of Medicine have launched a clinical trial to assess the safety and efficacy of convalescent plasma to prevent COVID-19 after a known exposure to the virus.   Convalescent plasma therapy involves infusing patients with antibodies extracted from the blood of donors who have successfully...
Source: COVID-19 Clinical Trials  Jul 10, 2020  5 days ago
COVID-19 Clinical Trials: Medical researchers are saying that low-dose radiation therapy seems to improve outcomes for COVID-19 patients. At least a dozen clinical trials are underway throughout the world to further explore the benefits. https://clinicaltrials.gov/ct2/results?cond=COVID-19&term=low-dose+radiation&cntry=&state=&city=&dist=   The latest two trial...
Source: COVID-19 Vaccines  Jul 10, 2020  5 days ago
COVID-19 Vaccines: The U.S.National Institute of Allergy & Infectious Diseases (NIAID) has founded a new clinical trials network focused on enrolling volunteers in clinical trials for COVID-19 vaccines and monoclonal antibodies.   Various media have recently reported that sponsor companies are struggling to enroll patients in clinical trials for COVID-19 va...
Source: COVID-19 Controversies  Jul 10, 2020  5 days ago
COVID-19 Controversies: Despite the fact that Pharmaceutical giant Gilead has huge resources and research facilities, it was never demonstrated that Remdesivir had any direct effects in terms of inhibiting the SARS-CoV-2 replication capability in vitro or vivo studies. The only things it had that made the Trump administration pass the FDA approval as a drug for COVID-19 was 'half-baked' st...
Source: COVID-19 Drugs  Jul 10, 2020  5 days ago
COVID-19 Drugs: Despite numerous studies showing that Lopinavir and Ritonavir are not effective to treat COVID-19, we still have numerous ignorant countries and doctors still using those drugs in their treatment protocols. Now a new French study shows that older, critically ill patients with COVID-19 who received a combination of the antiretroviral medications lopinavir and ritonavir experienced ...
Source: COVID-19 Genomics  Jul 09, 2020  6 days ago
COVID-19 Genomics: University Of Otago-New Zealand researchers studying the SARS-CoV-2 coronavirus has discovered that a particular binding site of virus targeting host microRNA miR197-5p has mutated more than 40 times since March and is now present in more than 75 percent of SARS-CoV-2 global isolates. The findings also have implications for cardiovascular issues.   The research findings w...
Source: COVID-19 Drugs  Jul 09, 2020  6 days ago
COVID-19 Drugs: There is now an increased demand for a variety of drugs to treat the growing variety of symptoms and conditions associated with COVID-19. One of which is the assortment of different types of neurological conditions. Just for one neurological category of symptoms which is delirium, BioXcel Therapeutics, which is based in Connecticut has developed a new drug called BXCL510.   ...
Source: COVID-19 Drugs  Jul 09, 2020  6 days ago
COVID-19 Drugs: R-Pharm, a Russian pharmaceutical company has secured regulatory approval for the use of its antiviral drug Coronavir, to treat patients suffering from Covid-19. The company released the announcement today to Russian media.   The regulatory approval comes after a clinical trial in mild to moderate Covid-19 patients showed that the drug is highly effective in blocking replica...
Source: COVID-19 Genomics  Jul 09, 2020  6 days ago
COVID-19 Genomics:  Swiss Researchers from the Institute of Molecular Biology and Biophysics-Zurich, University of Bern and Institute of Virology and Immunology-Bern have discovered the detailed functional process by which the SARS-CoV-2 coronavirus NSP1 Protein Inhibits Host Translation.   Their study published in a preprint server shows that the 5’ end of the RNA molecule is ca...
Source: COVID-19 Disinfectants  Jul 09, 2020  6 days ago
COVID-19 Disinfectants: The American Environmental Protection Agency (EPA) just approved two disinfection sprays that can kill severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes the coronavirus disease (COVID-19), on surfaces. The agency gave the green light to Lysol Disinfectant Spray, and Lysol Disinfectant Max Cover Mist, as two products that can effectively kil...
Source: COVID-19 Nutrition  Jul 09, 2020  6 days ago
COVID-19 Nutrition: A new but intriguing European study involving the collaboration of 13 research centers and universities in Germany, Spain, Portugal, Franca and Switzerland suggests that COVID-19 mortality rates are likely to be lower in countries where diets are rich in fermented vegetables.   Though the study is published on a preprint server, it is currently being peer-reviewed by a f...
Source: COVID-19 Diagnostics  Jul 09, 2020  6 days ago
COVID-19 Diagnostics: Researchers from the University of Exeter have developed a revolutionary new device that could allow health professionals to accurately test patients' antibody response to COVID-19 in as little as seven minutes.   The new pioneering COVID-19 Triple Antibody Test has been produced by the University of Exeter spin-out company Attomarker Ltd and is set to spearhead th...
Source: COVID-19 Alert  Jul 08, 2020  7 days ago
COVID-19 Alert: Medical researchers from Cedars-Sinai Medical Center, Michigan Medicine and UCLA Fielding School of Public Health have found an association between proton pump inhibitors (PPIs) and risk of COVID-19 in an observational study of more than 53,000 Americans.It was found that PPIs usage was linked with a higher risk for COVID-19. This places the usage of PPIs for heartburn and gastric...
Source: COVID-19 Research  Jul 08, 2020  7 days ago
COVID-19 Research: German researchers from Max Planck Institute, Frankfurt Institute for Advanced Studies and the Institute of Biophysics, Goethe University-Frankfurt have conducted a news study on the structural dynamics of the SARS-CoV-2 spike protein and have identified epitopes that could be possible immune targets for the development of vaccines or other therapeutics.   The resear...
Source: COVID-19 Neurology  Jul 08, 2020  7 days ago
COVID-19 Neurology: German researchers from Charité - Universitätsmedizin Berlin have shown that the neurological symptoms observed in some COVID-19 patients may be caused by autoantibodies targeting the brain.   The research team says that although some autoantibodies still need to be identified, they may at least partly explain the multiple organ disease that can occur in COVI...
Source: COVID-19 Drugs  Jul 08, 2020  7 days ago
COVID-19 Drugs: Medical researchers from Queensland University of Technology and Oxford University are working in collaboration to begin human clinical trials of inhaled corticosteroids, commonly used for asthma patients, on patients with COVID-19. The researchers believe that this could be useful for patients with the novel coronavirus infection. Research has shown that some corticosteroids,&nbs...
Source: COVID-19 Innovations  Jul 08, 2020  7 days ago
COVID-19 Innovations: Experts from the University of Houston, in collaboration with a private company called Medistar, have designed a "catch and kill" air filter that can trap the coronavirus responsible for COVID-19, killing it instantly.   Dr Zhifeng Ren, director of the Texas Center for Superconductivity at UH, collaborated with Monzer Hourani, CEO of Medistar, a Houston-based...
Source: COVID-19 Vaccine Updates  Jul 08, 2020  7 days ago
COVID-19 Vaccine Updates: Maryland based Biotech company Novavax announced that it has been awarded US$1.6 billion toward late-stage clinical trials and large-scale manufacturing to produce 100 million doses of its COVID-19 vaccine starting this year through the Trump’s administration “Operation Warp Speed” program.   The new funding will enable Novavax  to complete la...
Source: COVID-19 Neurology  Jul 08, 2020  7 days ago
COVID-19 Neurology:  A new study by University College London (UCL) and University College London Hospitals (UCLH) indicate that more neurological conditions are being manifested in COVID-19 patients. Besides delirium, brain inflammation, stroke and nerve damage, a large number of patients are now shown to be inflicted with ADEM or Acute Disseminated Encephalomyelitis and its prevalence is gr...

MOST READ

Source: COVID-19 Blood Clots
May 20, 2020  2 months ago
Source : Thailand Medical news
Feb 05, 2020  5 months ago

Interesting Reads

Source: COVID-19 Convalescent Plasma and Hyperimmune Plasma Or H-Ig Therapies
Jun 15, 2020  1 month ago
Source: Nitric Oxide and COVID-19
Jun 15, 2020  1 month ago
Source: COVID-19 Asymptomatic and Presymptomatic
Jun 14, 2020  1 month ago
Source: COVID-19 Long-Term Health Implications
Jun 13, 2020  1 month ago
Source: COVID-19, Influenza and Next Wave
Jun 10, 2020  1 month ago
Source: Myocardial Injury
Jun 09, 2020  1 month ago
Source: Hartmann-Boyce, Jamie & Lindson, Nicola – Converzation
Jun 03, 2020  1 month ago
Source: COVID-19 News
May 21, 2020  2 months ago
Source: Covid-19 Treatments And Drugs News
Mar 20, 2020  4 months ago
Source: SARS-Cov-2 Coronavirus Research
Mar 08, 2020  4 months ago
Source : Thailand Medical News
Feb 11, 2020  5 months ago
Source: Thailand Medical News
Feb 10, 2020  5 months ago
Source: Thailand Medical News
Feb 09, 2020  5 months ago